Carisbamate as adjunctive treatment of partial onset seizures in adults in two randomized, placebo-controlled trials

Epilepsia

Volumn 51, Issue 3, 2010, Pages 333-343

  Sperling, Michael R ^a   Greenspan, Andrew ^b   Cramer, Joyce A ^c   Kwan, Patrick ^d   Kälviäinen, Reetta ^e   Halford, Jonathan J ^f   Schmitt, Jennifer ^b   Yuen, Eric ^b   Cook, Thomas ^g   Haas, Magali ^h   Novak, Gerald ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^c YALE UNIVERSITY   (United States)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^e KUOPIO UNIVERSITY HOSPITAL   (Finland)

^f MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^g UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^h JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

Adjunctive; Antiepileptic; Carisbamate; Partial onset seizures; Uridine diphosphate glucuronosyltransferase

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CARISBAMATE; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; PLACEBO; TOPIRAMATE; UNCLASSIFIED DRUG; VALPROIC ACID;

ADJUVANT THERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPILEPSY; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SEIZURE; SOMNOLENCE; STEADY STATE; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; CARBAMATES; DIZZINESS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; EPILEPSIES, PARTIAL; FEMALE; GLUCURONOSYLTRANSFERASE; HUMANS; MALE; MIDDLE AGED; PLACEBOS; SLEEP; TREATMENT OUTCOME;

EID: 77749270555     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2009.02318.x     Document Type: Article

References (17)

1. Bialer M. (2006) New antiepileptic drugs that are second generation to existing antiepileptic drugs. Expert Opin Investig Drugs 15:637-647.
2. Bialer M, Johannessen SI, Levy RH, Perucca E, Tomson T, White HS. (2009) Progress report on new antiepileptic drugs: a summary of the Ninth Eilat Conference (EILAT IX). Epilepsy Res 83:1-43.
3. Brodie MJ. (2001) Do we need any more new antiepileptic drugs? Epilepsy Res 45:3-6.
4. Chien S, Bialer M, Solanki B, Verhaeghe T, Doose DR, Novak G, Yao C. (2006) Pharmacokinetic interaction study between the new antiepileptic and CNS drug RWJ-333369 and carbamazepine in healthy adults. Epilepsia 47:1830-1840.
5. Chien S, Yao C, Mertens A, Verhaeghe T, Solanki B, Doose DR, Novak G, Bialer M. (2007) An interaction study between the new antiepileptic and CNS drug carisbamate (RWJ-333369) and lamotrigine and valproic acid. Epilepsia 48:1328-1338.
6. Cramer JA. (1995) Optimizing long-term patient compliance. Neurology 45:S25-S28.
7. Faught E, Holmes G, Rosenfeld W, Novak G, Neto W, Greenspan A, Schmitt J, Yuen E, Reines S, Haas M. (2008) Randomized, controlled, dose-ranging trial of carisbamate for partial-onset seizures. Neurology 71:1586-1593.
8. Francois J, Boehrer A, Nehlig A. (2008) Effects of carisbamate (RWJ-333369) in two models of genetically determined generalized epilepsy, the GAERS and the audiogenic Wistar AS. Epilepsia 49:393-399.
9. Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Chadwick D, Guerreiro C, Kalviainen R, Mattson R, Perucca E, Tomson T. (2006) ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 47:1094-1120.
10. Grabenstatter HL, Dudek FE. (2008) A new potential AED, carisbamate, substantially reduces spontaneous motor seizures in rats with kainate-induced epilepsy. Epilepsia 49:1787-1794.
11. Levy R, Ragueneau-Majlessi I, Solanki B, Zannikos P, Yao C, Novak G. (2008) Pharmacokinetics, safety, and tolerability of the new antiepileptic carisbamate in the elderly. Epilepsy Res 79:22-30.
12. Liu Y, Yohrling GJ, Wang Y, Hutchinson TL, Brenneman DE, Flores CM, Zhao B. (2009) Carisbamate, a novel neuromodulator, inhibits voltage-gated sodium channels and action potential firing of rat hippocampal neurons. Epilepsy Res 83:66-72.
13. Novak GP, Kelley M, Zannikos P, Klein B. (2007) Carisbamate (RWJ-333369). Neurotherapeutics 4:106-109.
14. Novak G, De Ridder F, Hing J. (2008) PK/PD modeling of the effect of carisbamate (RWJ-333369) as adjunctive therapy is patients with refractory partial onset seizures. Epilepsia 49:115.
15. Onat F, Ozkara C. (2004) Adverse effects of new antiepileptic drugs. Drugs Today (Barc) 40:325-342.
16. Stacey WC, Litt B. (2008) Technology insight: neuroengineering and epilepsy-designing devices for seizure control. Nat Clin Pract Neurol 4:190-201.
17. Yao C, Doose DR, Novak G, Bialer M. (2006) Pharmacokinetics of the new antiepileptic and CNS drug RWJ-333369 following single and multiple dosing to humans. Epilepsia 47:1822-1829.